ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 258 filers reported holding ACCELERON PHARMA INC in Q4 2020. The put-call ratio across all filers is 0.78 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $3,952,000 | +37.1% | 22,964 | 0.0% | 0.31% | +38.3% |
| Q2 2021 | $2,882,000 | -7.5% | 22,964 | 0.0% | 0.22% | -14.0% |
| Q1 2021 | $3,114,000 | +6.0% | 22,964 | 0.0% | 0.26% | +1.6% |
| Q4 2020 | $2,938,000 | +13.7% | 22,964 | 0.0% | 0.25% | +4.1% |
| Q3 2020 | $2,584,000 | +18.1% | 22,964 | 0.0% | 0.24% | +8.0% |
| Q2 2020 | $2,188,000 | -33.3% | 22,964 | -50.0% | 0.23% | +27.0% |
| Q1 2020 | $3,282,000 | +169.5% | 45,928 | +100.0% | 0.18% | +49.6% |
| Q4 2019 | $1,218,000 | -6.5% | 22,964 | -30.3% | 0.12% | -13.8% |
| Q3 2019 | $1,302,000 | -26.2% | 32,964 | -23.3% | 0.14% | -26.2% |
| Q2 2019 | $1,765,000 | -11.8% | 42,964 | 0.0% | 0.19% | -11.8% |
| Q1 2019 | $2,001,000 | +6.9% | 42,964 | 0.0% | 0.21% | -6.6% |
| Q4 2018 | $1,871,000 | -23.9% | 42,964 | 0.0% | 0.23% | -6.6% |
| Q3 2018 | $2,459,000 | +17.9% | 42,964 | 0.0% | 0.24% | +10.5% |
| Q2 2018 | $2,085,000 | – | 42,964 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darwin Global Management, Ltd. | 938,490 | $120,070,000 | 33.50% |
| Foresite Capital Management III, LLC | 108,630 | $13,898,000 | 16.15% |
| Octagon Capital Advisors LP | 112,363 | $14,376,000 | 4.98% |
| Artal Group S.A. | 1,400,000 | $179,116,000 | 3.84% |
| Avoro Capital Advisors LLC | 1,550,000 | $198,307,000 | 3.42% |
| Affinity Asset Advisors, LLC | 45,000 | $5,757,000 | 3.05% |
| NWI MANAGEMENT LP | 200,000 | $25,588,000 | 2.54% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 71,000 | $9,063,000 | 2.48% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,600,000 | $332,644,000 | 2.00% |
| Parkman Healthcare Partners LLC | 52,458 | $6,711,000 | 1.72% |